A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...
Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
Apple customers are generally a shockingly loyal bunch. The company's high repeat customer rate can be attributed to a combination of factors that concern iPhones themselves as well as Apple's ...
Biohaven Pharmaceuticals BHVN recently announced that the phase II/III HEALY ALS platform study evaluating verdiperstat for treating Amyotrophic Lateral Sclerosis (ALS) failed. ALS is a progressive, ...
UNESCO warned that the “low prevalence of fact-checking highlights influencers’ vulnerability to misinformation, which can have far-reaching consequences for public trust and discourse.” According to ...
NEW YORK, Feb. 23 (UPI) --A new study that compares the label accuracy of a generic drug versus a dietary supplement with the same active pharmaceutical ingredient found that the supplement fared very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results